Friday, July 10, 2026

pharma · Monocarboxylate Transporter 8 (MCT8) deficiency

Rare Thyroid Therapeutics

Rare Thyroid Therapeutics trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Stockholm, SE HQ
2017 Founded
1 Employees
EMA registrant Type
Company details
Status
Public
HQ
Stockholm, SE
Founded
2017
Employees
1
Programs
2
Drugs
6
Patents
0
Intelligence · Clinical Trials

Rare Thyroid Therapeutics clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Rare Thyroid Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Rare Thyroid Therapeutics trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for Rare Thyroid Therapeutics.

  1. MCT8-2021-3 — Phase 3

    Clinical update
  2. Tiratricol, Tiratricol — Phase 2

    Clinical update

Trial registry

2 studies